{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T11:59:04Z","timestamp":1772366344933,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T00:00:00Z","timestamp":1431129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00467-015-3123-5","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T14:34:26Z","timestamp":1431095666000},"page":"1371-1374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies"],"prefix":"10.1007","volume":"30","author":[{"given":"Meghan H.","family":"Pearl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Leuchter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine F.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Ettenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen W.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,9]]},"reference":[{"key":"3123_CR1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00007890-196805000-00010","volume":"6","author":"PJ Morris","year":"1968","unstructured":"Morris PJ, Williams GM, Hume DM, Mickey MR, Terasaki PI (1968) Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man. Transplantation 6:392\u2013399","journal-title":"Transplantation"},{"key":"3123_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","volume":"95","author":"BD Tait","year":"2013","unstructured":"Tait BD, Susal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G (2013) Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 95:19\u201347","journal-title":"Transplantation"},{"key":"3123_CR3","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","volume":"23","author":"S Mohan","year":"2012","unstructured":"Mohan S, Palanisamy A, Tsapepas D, Tanriover B, Crew RJ, Dube G, Ratner LE, Cohen DJ, Radhakrishnan J (2012) Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 23:2061\u20132071","journal-title":"J Am Soc Nephrol"},{"key":"3123_CR4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","volume":"352","author":"D Dragun","year":"2005","unstructured":"Dragun D, Muller DN, Brasen JH, Fritsche L, Nieminen-Kelha M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schonemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat G (2005) Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352:558\u2013569","journal-title":"N Engl J Med"},{"key":"3123_CR5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","volume":"90","author":"NL Reinsmoen","year":"2010","unstructured":"Reinsmoen NL, Lai CH, Heidecke H, Haas M, Cao K, Ong G, Naim M, Wang Q, Mirocha J, Kahwaji J, Vo AA, Jordan SC, Dragun D (2010) Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in donor HLA antibody negative patients. Transplantation 90:1473\u20131477","journal-title":"Transplantation"},{"key":"3123_CR6","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","volume":"13","author":"M Giral","year":"2013","unstructured":"Giral M, Foucher Y, Dufay A, Van Huyen JP, Renaudin K, Moreau A, Philippe A, Hegner B, Dechend R, Heidecke H, Brouard S, Cesbron A, Castagnet S, Devys A, Soulillou JP, Dragun D (2013) Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant 13:2567\u20132576","journal-title":"Am J Transplant"},{"key":"3123_CR7","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","volume":"13","author":"M Taniguchi","year":"2013","unstructured":"Taniguchi M, Rebellato LM, Cai J, Hopfield J, Briley KP, Haisch CE, Catrou PG, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI (2013) Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant 13:2577\u20132589","journal-title":"Am J Transplant"},{"key":"3123_CR8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/TP.0b013e3182157d60","volume":"91","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Cecka JM, Gjertson DW, Ge P, Rose ML, Patel JK, Ardehali A, Kobashigawa JA, Fishbein MC, Reed EF (2011) HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation 91:1153\u20131158","journal-title":"Transplantation"},{"key":"3123_CR9","first-page":"571","volume":"56","author":"M Kami\u0144ska","year":"2005","unstructured":"Kami\u0144ska M, Mogielnicki A, Stankiewicz A, Kramkowski K, Domaniewski T, Buczko W, Chabielska E (2005) Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats. J Physiol Pharmacol 56:571\u2013585","journal-title":"J Physiol Pharmacol"},{"key":"3123_CR10","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/1529-0131(200111)44:11<2467::AID-ART426>3.0.CO;2-U","volume":"44","author":"PM Dobado-Berrios","year":"2001","unstructured":"Dobado-Berrios PM, Lopez-Pedrera C, Velasco F, Cuadrado MJ (2001) The role of tissue factor in the antiphospholipid syndrome. Arthritis Rheum 44:2467\u20132476","journal-title":"Arthritis Rheum"},{"key":"3123_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.102.3.357","volume":"102","author":"H Holschermann","year":"2000","unstructured":"Holschermann H, Bohle RM, Schmidt H, Zeller H, Fink L, Stahl U, Grimm H, Tillmanns H, Haberbosch W (2000) Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts. Circulation 102:357\u2013363","journal-title":"Circulation"},{"key":"3123_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/TP.0b013e3182529bb7","volume":"94","author":"I Lukitsch","year":"2012","unstructured":"Lukitsch I, Kehr J, Chaykovska L, Wallukat G, Nieminen-Kelha M, Batuman V, Dragun D, Gollasch M (2012) Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies. Transplantation 94:8\u201313","journal-title":"Transplantation"},{"key":"3123_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.thromres.2010.09.008","volume":"127","author":"MM Samama","year":"2011","unstructured":"Samama MM (2011) The mechanism of action of rivaroxaban\u2013an oral, direct Factor Xa inhibitor\u2013compared with other anticoagulants. Thromb Res 127:497\u2013504","journal-title":"Thromb Res"},{"key":"3123_CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0038-1648875","volume":"72","author":"CN Berry","year":"1994","unstructured":"Berry CN, Girardot C, Lecoffre C, Lunven C (1994) Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin. Thromb Haemost 72:381\u2013386","journal-title":"Thromb Haemost"},{"key":"3123_CR15","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.jacc.2007.02.065","volume":"49","author":"RP Giugliano","year":"2007","unstructured":"Giugliano RP, Wiviott SD, Stone PH, Simon DI, Schweiger MJ, Bouchard A, Leesar MA, Goulder MA, Deitcher SR, McCabe CH, Braunwald E, Investigators A-T- (2007) Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial. J Am Coll Cardiol 49:2398\u20132407","journal-title":"J Am Coll Cardiol"},{"key":"3123_CR16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/hc2601.091386","volume":"104","author":"A Lee","year":"2001","unstructured":"Lee A, Agnelli G, Buller H, Ginsberg J, Heit J, Rote W, Vlasuk G, Costantini L, Julian J, Comp P, van Der Meer J, Piovella F, Raskob G, Gent M (2001) Dose\u2013response study of recombinant factor VIIa\/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation 104:74\u201378","journal-title":"Circulation"},{"issue":"158","key":"3123_CR17","first-page":"e151","volume":"211","author":"LM Amaral","year":"2014","unstructured":"Amaral LM, Kiprono L, Cornelius DC, Shoemaker C, Wallace K, Moseley J, Wallukat G, Martin JN Jr, Dechend R, LaMarca B (2014) Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy. Am J Obstet Gynecol 211(158):e151\u2013e156","journal-title":"Am J Obstet Gynecol"},{"key":"3123_CR18","author":"I Kim","year":"2014","unstructured":"Kim I, Wu G, Chai NN, Klein AS, Jordan S (2014) Anti-interleukin 6 receptor antibodies attenuate antibody recall responses in a mouse model of allosensitization. Transplantation. doi: 10.1097\/TP.0000000000000437","journal-title":"Transplantation"},{"key":"3123_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","volume":"9","author":"DK Perry","year":"2009","unstructured":"Perry DK, Burns JM, Pollinger HS, Amiot BP, Gloor JM, Gores GJ, Stegall MD (2009) Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant 9:201\u2013209","journal-title":"Am J Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3123-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-015-3123-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3123-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T19:46:25Z","timestamp":1566675985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-015-3123-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,9]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3123"],"URL":"https:\/\/doi.org\/10.1007\/s00467-015-3123-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,9]]}}}